BioengineeringbioRxiv
Glycosylation-modified antigens as an inverse vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy
S. Cao, C. D. Maulloo, M. M. Raczy…·J. A. Hubbell
This paper develops a glycosylation-modified antigen vaccine platform that prevents anaphylaxis in a cow's milk allergy mouse model by inducing antigen-specific non-responsiveness.
DOI 10.1016/j.xcrm.2023.101346